Evaluation of Cardiac Biomarkers for Early Diagnosis of Dilated Cardiomyopathy in Dogs

Mukesh K. Srivastava

Department of Veterinary Medicine, DUVASU, Mathura (U.P.), India.

Anil Ahuja

Department of Veterinary Medicine, CVAS,RAJUVAS, Bikaner, Rajasthan, India.

R.D. Velhankar

Department of Veterinary Medicine, CVAS,RAJUVAS, Bikaner, Rajasthan, India.

Ashish Srivastav

Department of Veterinary Medicine, DUVASU, Mathura (U.P.), India.

Barkha Sharma

Department of Veterinary Epidemiology, DUVASU, Mathura (U.P.), India.

Arpana Raikwar *

Department of Veterinary Medicine College of Veterinary Science and A.H., Jabalpur (M.P.), India.

*Author to whom correspondence should be addressed.


Abstract

Cardiac biomarkers play a crucial role in diagnosing heart disease in veterinary medicine. This collaborative study, involving 2497 dogs of various breeds, ages, and genders, was conducted collaboratively at the Department of Veterinary Clinical Medicine, College of Veterinary and Animal Science, RAJUVAS, Bikaner, and the Chandrika Chimanlal Doshi Cardiovascular Unit for Animals, Department of Veterinary Clinical Medicine, Ethics, and Jurisprudence, Bombay Veterinary College, Parel, Mumbai-12.Through meticulous examination, including historical analysis, clinical evaluation, and advanced diagnostic techniques like echocardiography, researchers conclusively diagnosed 29 cases of Dilated Cardiomyopathy (DCM).

Canine-specific cardiac Troponin I (cTnI) levels were measured, showing significant differences between healthy and DCM-affected dogs. Among DCM cases, bilaterally affected dogs exhibited the highest cTnI levels. Similarly, B-type natriuretic peptide (BNP) analysis revealed significant differences between healthy and DCM-affected dogs, with notably elevated levels in bilaterally affected dogs. N-Terminal-pro-BNP analysis also indicated significant differences between healthy and DCM-affected dogs.

However, atrial natriuretic peptide (ANP) analysis showed no significant differences between healthy and DCM-affected dogs, except for lower levels observed in right DCM cases. Endothelin 1 analysis showed non-significant differences between healthy and DCM-affected dogs, except for higher levels in bilateral DCM cases.

While these biomarkers offer promising diagnostic insights, they have limitations. Proper sample handling, longer turnaround times, and the necessity for concurrent analysis of renal and hepatic function are crucial considerations. Additionally, these biomarkers complement but do not replace other diagnostic methods such as radiography and echocardiography. Further research in larger dog populations is warranted to validate and refine these findings.

Keywords: Cardiac biomarker, cardiomyopathy, cardiac troponin I, endothelin-1


How to Cite

Srivastava, M. K., Ahuja , A., Velhankar, R., Srivastav, A., Sharma , B., & Raikwar , A. (2024). Evaluation of Cardiac Biomarkers for Early Diagnosis of Dilated Cardiomyopathy in Dogs. UTTAR PRADESH JOURNAL OF ZOOLOGY, 45(8), 211–220. https://doi.org/10.56557/upjoz/2024/v45i84015

Downloads

Download data is not yet available.

References

Oyama MA, Sisson DD, Solter PF. Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations. Am. J. Vet. Res. 2007;68:42-47.

Sisson DD, Thomas WP, Bonagura JD. Congenital Heart Disease and Primary myocardial disease in the dog. In: Ettinger SJ, Feldman EC, Eds. Text Book of Veterinary Internal Medicine. WB Saunders Company, Philadelphia. 2000;737-786:874-895.

Anthony S, McLean, Stephen J, Huang and Mark, Salter. Bench-to-bedside review: The value of cardiac biomarkers in the intensive care patient. Crit. Care. 2008;12(3):215.

McLean AS, Huang SJ, Mark Salter. Bench-to-bedside review: The value of cardiac biomarkers in the intensive care patient. Crit. Care. 2008;12(3):1-9.

Fabio Cilli, Hatim IK. Alibhai, Elizabeth, Armitage-Chan, Adrian Boswood., Richard, A. Hammond. and Shailen, Jasani. Incidence of elevation of cardiac troponin I prior to and following routine general anesthesia in dogs. Vet. Anes. Analg. 2010;37(5):409-16.

Melter J, Paul, Richard J, Mellanby, Elizabeth A. Baines., Elizabeth J. Villiers., Joy Archer. and Michael E. Herrtage. High serum troponin I concentration as a marker of severe myocardial damage in a case of suspected exertional heatstroke in a dog. J.Vet. Cardiol. 2006;8:55-62.

Schultze AE, Konrad RJ, Credille KM, Lu Q, A. Todd J. Ultrasensitive Cross-species Measurement of Cardiac Troponin-I Using the Erenna Immunoassay System. Toxicologic Pathology. 2008;36:777-782.

Ljungvall I, Hoglund K, Tidholm A, Olsen LH, Borgarelli M, Venge P, Haggstrom J. Cardiac troponin I is associated with severity of myxomatous mitral valve disease, age, and C-reactive protein in dogs. J. Vet. Intern. Med. 2010;24(1):153-9.

Luchner A, Stevens TL, Borgeson DD, Redfield M, Wei CM, Porter JG, Burnett JC, Jr. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am. J. Physiol. 1998;274:1684-1689.

Noszczyk Nowak A. NT-pro-BNP and troponin I as predictors of mortality in dogs with heart failure. Pol. J. Vet. Sci. 2011;14(4):551-556.

Tsai SH, Lin YY, Chu SJ, Hsu CW, Cheng SM. Interpretation and use of natriuretic peptides in non-congestive heart failure settings. Yonsei Medical Journal. 2010;51:151-163.

Hori Y, Sano N, Kanai K, Hoshi F, Itoh N, Higuchi S. Acute cardiac volume load-related changes in plasma atrial natriuretic peptide and N-terminal pro-B-type natriuretic peptide concentrations in healthy dogs. Vet. J. 2010;185:317-321.

Asano K, Masuda K, Okumura M, Kadosawa T, Fujinaga T. Plasma atrial and brain natriuretic peptide levels in dogs with congestive heart failure. J. Vet. Med. Sci. 1999;61:523-529.

Widmaier EP, Hershel R, Kevin TS. Vander's Human Physiology, 11th Ed. McGraw-Hill. 2008; 509-510.

Tessier-Vetzel D, Tissier R, Chetboul V, Carlos C, Nicolle A, Benbaron D, Dandrieux J, Thoulon J, Carayonm A, Pouchelon JL. Diagnostic and prognostic value of endothelin-1 plasma concentrations in dogs with heart and respiratory disorders. Vet. Rec. 2006;158(23):783-788.